Used in the treatment of major depressive disorder as an adjunct to antidepressant therapy and for the management of schizophrenia. It functions as a partial agonist at serotonin 5-HT1A and dopamine D2 receptors, helping to modulate neurotransmission involved in mood and cognition. Its pharmacological profile offers a favorable balance between efficacy and reduced risk of certain side effects, such as extrapyramidal symptoms, compared to other antipsychotics. Commonly prescribed in adult populations, it is available in oral tablet and orally disintegrating tablet forms for flexible dosing.